CO4750820A1 - Composiciones que contienen un activo farmaceutico analge- sico y un agente antihistaminico de eter de pirrolidina o piperidina y, opcionalmente, un compuesto alfa-agonista y/o cafeina - Google Patents

Composiciones que contienen un activo farmaceutico analge- sico y un agente antihistaminico de eter de pirrolidina o piperidina y, opcionalmente, un compuesto alfa-agonista y/o cafeina

Info

Publication number
CO4750820A1
CO4750820A1 CO96039940A CO96039940A CO4750820A1 CO 4750820 A1 CO4750820 A1 CO 4750820A1 CO 96039940 A CO96039940 A CO 96039940A CO 96039940 A CO96039940 A CO 96039940A CO 4750820 A1 CO4750820 A1 CO 4750820A1
Authority
CO
Colombia
Prior art keywords
pirrolidine
agonist
alpha
optionally
compositions containing
Prior art date
Application number
CO96039940A
Other languages
English (en)
Inventor
Ronald Dean Cramer
Sekhar Mitra
Donald Kay Riker
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4750820A1 publication Critical patent/CO4750820A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

.- la presente invención se refiere a composiciones para proveer untratamiento mejorado, manejo o mitigación de los síntomas del resfriado, similares al resfriado, alergia, sinusitis y/o de la gripe, mediante la administración de una cantidad segura y eficaz de una composición que consiste esencialmente de: (a) un activo farmacéutico analgésico; y (b) un agente antihistamínico de éter de pirrolidina o piperidina de la fórmula: en donde R1 es un radical que se selecciona del grupo que consiste de hidrógeno, halógeno, alquilo inferior que contiene de 1 a 4 átomos de carbono, R2 es un radical que se selecciona del grupo que consiste de alquilo inferior que contiene de 1 a 4 átomos de carbono, m es un número entero de 0, 1, 2 y 3 y n es un número entero de 1 a 2, con la condición de que m + n debe ser por lo menos 2.
CO96039940A 1995-07-28 1996-07-29 Composiciones que contienen un activo farmaceutico analge- sico y un agente antihistaminico de eter de pirrolidina o piperidina y, opcionalmente, un compuesto alfa-agonista y/o cafeina CO4750820A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50877595A 1995-07-28 1995-07-28
US61152896A 1996-03-05 1996-03-05

Publications (1)

Publication Number Publication Date
CO4750820A1 true CO4750820A1 (es) 1999-03-31

Family

ID=27056302

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96039940A CO4750820A1 (es) 1995-07-28 1996-07-29 Composiciones que contienen un activo farmaceutico analge- sico y un agente antihistaminico de eter de pirrolidina o piperidina y, opcionalmente, un compuesto alfa-agonista y/o cafeina

Country Status (8)

Country Link
EP (1) EP0841947A1 (es)
JP (1) JPH11510168A (es)
AR (1) AR003470A1 (es)
AU (1) AU6599196A (es)
CA (1) CA2227958A1 (es)
CO (1) CO4750820A1 (es)
PE (1) PE12098A1 (es)
WO (1) WO1997004808A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
AU8744398A (en) * 1997-09-19 1999-04-12 Procter & Gamble Company, The Compositions and methods for treating respiratory disorders
DE60232445D1 (de) 2001-06-28 2009-07-09 Ucb Farchim Sa Cetirizin und pseudoephedrin enthaltende tablette
KR20040045429A (ko) * 2001-09-04 2004-06-01 베링거 인겔하임 인터내셔날 게엠베하 항인플루엔자 약제
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
RU2286770C2 (ru) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Антигриппозное средство
JP5598108B2 (ja) * 2009-07-09 2014-10-01 ライオン株式会社 内服用固形組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
EP0550668A4 (en) * 1990-09-28 1993-10-13 Merck & Co. Inc. Ibuprofen-antihistamine combinations
EP0661967B1 (en) * 1991-11-19 1999-08-25 University Of Virginia Patent Foundation Combined virustatic antimediator (covam) treatment of common colds
GB9222849D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel use of pharmaceutical compositions
AU672279B2 (en) * 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen

Also Published As

Publication number Publication date
CA2227958A1 (en) 1997-02-13
JPH11510168A (ja) 1999-09-07
PE12098A1 (es) 1998-04-19
WO1997004808A1 (en) 1997-02-13
AR003470A1 (es) 1998-08-05
AU6599196A (en) 1997-02-26
EP0841947A1 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
BR0114042A (pt) Composição catártica
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
DE69531457D1 (en) Sulfonamide
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
BR0113961A (pt) Método de analgesia
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
AR033359A1 (es) Compuesto amidino, composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento para inhibir la sintesis de oxido nitrico
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
BR0012488A (pt) Composição farmacêutica, métodos para melhorar a taxa de absorção de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para melhorar o inìcio do benefìcio terapêutico de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para inibição de gastroirritação em um mamìfero, e para tratamento de mamìferos necessitando do tratamento proporcionado por um ou mais do que um agente farmaceuticamente ativo, e, processo para preparar uma composição farmacêutica
MX174018B (es) Composiciones generadoras de gas que contienen nitrotriazolona
ES2193391T3 (es) Antagonistas muscarinicos.
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
CO4750820A1 (es) Composiciones que contienen un activo farmaceutico analge- sico y un agente antihistaminico de eter de pirrolidina o piperidina y, opcionalmente, un compuesto alfa-agonista y/o cafeina
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2084168T3 (es) Composiciones antimalaricas.
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
DK0694545T3 (da) Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
AR247984A1 (es) Metodo para la preparacion de una composicion sinergica que tiene actividad antiplaca o antigingivitis
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
SE8205868D0 (sv) A titre de medicaments, certains derives de lŸacide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
MX9400038A (es) Composiciones y metodos para proveer un efecto analgesico mejorado.